Mirjam A. De Weijert
Nijmegen, GE 6500HB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer.
Journal: Neoplasia (New York, N.Y.)
Published: April 22, 2022
Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 09, 2015
Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia.
Journal: World journal of urology
Published: October 03, 2014
Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC.
Journal: Neoplasia (New York, N.Y.)
Published: September 12, 2014
Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments.
Journal: Neoplasia (New York, N.Y.)
Published: January 28, 2014
Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 08, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026